SEC Form 4 · accession 0000882104-15-000084
PDL BIOPHARMA, INC. · PDLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steffen Pietzke
Officer — Controller and CAO
Period of report
Dec 7, 2015
Accepted (ET)
Dec 7, 2015 · 6:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882104
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Dec 7, 2015 | P | 20,590 | $3.6392 | A | 20,590 | I | Held by Spouse |
Table II — derivative securities
No Table II lines on this filing.